Emerald Health Therapeutics, Inc. (EMHTF)
Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
At close: 03:05PM EDT
Show:
Annual
Income Statement
Currency in CAD. All numbers in thousandsBreakdown
ttm
2020-12-31
2019-12-31
2018-12-31
Total Revenue
10,401
11,740
20,319
1,948
Cost of Revenue
16,518
21,410
34,788
5,048
Gross Profit
-6,117
-9,670
-14,469
-3,099
Operating Expenses
Research Development
1,950
1,569
4,279
801.351
Selling General and Administrative
11,736
14,000
30,409
32,825
Total Operating Expenses
15,206
17,326
36,543
34,245
Operating Income or Loss
-21,323
-26,996
-51,012
-37,344
Interest Expense
1,049
4,973
-
218.6
Total Other Income/Expenses Net
-14,134
-12,653
-62,947
5,370
Income Before Tax
-33,863
-43,343
-113,005
-31,007
Income Tax Expense
-
196
-1,099
-23.611
Income from Continuing Operations
-34,059
-43,539
-111,907
-30,983
Net Income
-33,865
-42,952
-111,141
-30,577
Net Income available to common shareholders
-33,865
-42,952
-111,141
-30,577
Basic EPS
-
-0.22
-0.75
-0.22
Diluted EPS
-
-0.22
-0.75
-0.22
Basic Average Shares
-
193,205
147,961
141,443
Diluted Average Shares
-
193,205
147,961
141,443
EBITDA
-
-33,550
-44,582
-27,341
© 2022 Yahoo. All rights reserved.
